Literature DB >> 1450418

Effects of leukocyte depletion and UVB irradiation on alloantigenicity of major histocompatibility complex antigens in platelet concentrates: a comparative study.

K J Kao1.   

Abstract

Recent technologic advancement enables us to prepare leukocyte-depleted or UVB-irradiated platelet concentrates for possible prevention of primary HLA alloimmunization. However, it is yet not known which of these two approaches is more efficacious. Because well-controlled studies cannot be easily conducted in human subjects to answer this question, a series of experiments were performed using a mouse transfusion model. The results showed that 100% of CBA mice with H2k haplotype developed antibody to donor H2d major histocompatibility complex (MHC) antigens after two weekly transfusions of platelet concentrates containing 2000 leukocytes/microL. In contrast, only 50% of the mice became alloimmunized after receiving platelets containing < or = 2 leukocytes/microL. More impressively, none developed anti-H2d antibodies after receiving two platelet concentrates irradiated with 1,200 mJ/cm2 UVB. UVB irradiation was found to be equally effective in reducing the alloantigenicity of platelet concentrates regardless of whether they contained more than a fully immunogenic dose of leukocytes. The antibody titers determined after five weekly transfusions also supported the observation that UVB irradiation was more efficacious than a 3-log leukocyte depletion in the prevention of primary alloimmunization to MHC antigens. In addition, the studies showed that only transfusions of UVB-irradiated platelet products could induce the suppression of immunologic responses to donor MHC antigens in recipients and the induced immunologic suppression could not be further enhanced by gamma irradiation or by leukocyte depletion.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1450418

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  6 in total

1.  Essential role of OX40L on B cells in persistent alloantibody production following repeated alloimmunizations.

Authors:  Hiroshi Kato; Hidefumi Kojima; Naoto Ishii; Hidenori Hase; Yutaka Imai; Takashi Fujibayashi; Kazuo Sugamura; Testuji Kobata
Journal:  J Clin Immunol       Date:  2004-05       Impact factor: 8.317

2.  Leukoreduction and ultraviolet treatment reduce both the magnitude and the duration of the HLA antibody response.

Authors:  Rachael P Jackman; Xutao Deng; Douglas Bolgiano; Garth H Utter; Cathy Schechterly; Mila Lebedeva; Eva Operskalski; Naomi L Luban; Harvey Alter; Michael P Busch; Sherrill J Slichter; Philip J Norris
Journal:  Transfusion       Date:  2013-06-30       Impact factor: 3.157

3.  CTLA4-Ig prevents alloantibody production and BMT rejection in response to platelet transfusions in mice.

Authors:  Christopher R Gilson; Seema R Patel; James C Zimring
Journal:  Transfusion       Date:  2012-02-10       Impact factor: 3.157

4.  Endothelial Phospholipase Cγ2 Improves Outcomes of Diabetic Ischemic Limb Rescue Following VEGF Therapy.

Authors:  Yashika Rustagi; Ahmed S Abouhashem; Priyanka Verma; Sumit S Verma; Edward Hernandez; Sheng Liu; Manishekhar Kumar; Poornachander R Guda; Rajneesh Srivastava; Sujit K Mohanty; Sedat Kacar; Sanskruti Mahajan; Kristen E Wanczyk; Savita Khanna; Michael P Murphy; Gayle M Gordillo; Sashwati Roy; Jun Wan; Chandan K Sen; Kanhaiya Singh
Journal:  Diabetes       Date:  2022-05-01       Impact factor: 9.337

5.  Recapitulation of posttransfusion purpura by cross-strain platelet immunization in mice.

Authors:  Daniel W Bougie; Jessica Sutton; Richard H Aster
Journal:  Blood Adv       Date:  2020-01-28

6.  Storage-Induced Platelet Apoptosis Is a Potential Risk Factor for Alloimmunization Upon Platelet Transfusion.

Authors:  Anno Saris; Ivan Peyron; Pieter F van der Meer; Tor B Stuge; Jaap Jan Zwaginga; S Marieke van Ham; Anja Ten Brinke
Journal:  Front Immunol       Date:  2018-06-05       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.